Newswise — Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease. Finding drugs that can inhibit the infection caused by SARS-CoV-2 is an essential step to finding the vaccine that can definitively bring the spread of the virus to an end. In this regard, the URV's Cheminformatics and Nutrition research group has carried out a computational screening to predict whether there is a medicine authorised for treating another pathology that can inhibit the main protease of the virus (M-pro). This is key to the whole process because this enzyme plays an essential role in the replication of the virus.
Norbrook Laboratories Limited Recalls Veterinary Products to Provide Sterility Assurance
Vetoquinol USA, a world-class developer of veterinarian-approved formulas for animal healthcare products, today announced the launch of its newest product called Flexprofen™.
Market Place
Share
Share
